Keywords: zeneca, reports, accolate, plans, says, intends, submit

Zeneca Reports Accolate Plans

Article | 03 June 1996

Print This

- Zeneca says it intends to submit interaction data for its leuko-triene D4 antagonist Accolate (zafirlukast) well before the end of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in